Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 6, 2023; 11(31): 7583-7592
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7583
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7583
Table 4 Comparison of safety evaluation, and postoperative hospital stays and costs, n (%)
| UTI (n = 180) | Placebo (n = 181) | P value | |
| Granulocytopenia | 17 (9.44) | 14 (7.73) | 0.562 |
| Abnormal liver enzymes | 16 (8.88) | 11 (6.08) | 0.310 |
| Diarrhea | 44 (24.44) | 31 (17.12) | 0.087 |
| Vomiting | 34 (18.88) | 22 (12.15) | 0.077 |
| Allergies | 29 (16.11) | 15 (8.29) | 0.023 |
| Hospitalization stays, day, mean ± SD | 13.46 ± 4.56 | 14.13 ± 4.79 | 0.174 |
| Hospitalization costs, CNY×104, mean ± SD | 5.27 ± 2.28 | 5.12 ± 2.09 | 0.515 |
- Citation: Tao YN, Han Q, Jiao W, Yang LK, Wang F, Xue S, Shen M, Wang YH. Effects of ulinastatin therapy in deep vein thrombosis prevention after brain tumor surgery: A single-center randomized controlled trial. World J Clin Cases 2023; 11(31): 7583-7592
- URL: https://www.wjgnet.com/2307-8960/full/v11/i31/7583.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i31.7583